Abbott India Limited (ABBOTINDIA) - Total Liabilities
Based on the latest financial reports, Abbott India Limited (ABBOTINDIA) has total liabilities worth Rs16.84 Billion INR (≈ $182.07 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore ABBOTINDIA net asset momentum to track the company's year-over-year net asset growth rate.
Abbott India Limited - Total Liabilities Trend (2005–2025)
This chart illustrates how Abbott India Limited's total liabilities have evolved over time, based on quarterly financial data. See ABBOTINDIA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Abbott India Limited Competitors by Total Liabilities
The table below lists competitors of Abbott India Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hundsun Technologies Inc
SHG:600570
|
China | CN¥4.49 Billion |
|
Gamuda Bhd
KLSE:5398
|
Malaysia | RM19.69 Billion |
|
Enel Chile S.A
SN:ENELCHILE
|
Chile | CL$7.10 Billion |
|
Ecopro BM. Co. Ltd
KQ:247540
|
Korea | ₩2.66 Trillion |
|
Karman Holdings Inc.
NYSE:KRMN
|
USA | $1.01 Billion |
|
Engie Brasil Energia S.A
F:7TE1
|
Germany | €43.90 Billion |
|
Life Time Group Holdings Inc
NYSE:LTH
|
USA | $4.84 Billion |
|
New China Life Insurance Company Ltd
F:NCL
|
Germany | €1.73 Trillion |
Liability Composition Analysis (2005–2025)
This chart breaks down Abbott India Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ABBOTINDIA market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.90 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Abbott India Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Abbott India Limited (2005–2025)
The table below shows the annual total liabilities of Abbott India Limited from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs16.84 Billion ≈ $182.14 Million |
+12.68% |
| 2024-03-31 | Rs14.95 Billion ≈ $161.64 Million |
+9.34% |
| 2023-03-31 | Rs13.67 Billion ≈ $147.83 Million |
-2.66% |
| 2022-03-31 | Rs14.04 Billion ≈ $151.87 Million |
+13.41% |
| 2021-03-31 | Rs12.38 Billion ≈ $133.92 Million |
+11.04% |
| 2020-03-31 | Rs11.15 Billion ≈ $120.60 Million |
+19.61% |
| 2019-03-31 | Rs9.32 Billion ≈ $100.83 Million |
+28.88% |
| 2018-03-31 | Rs7.23 Billion ≈ $78.24 Million |
+6.57% |
| 2017-03-31 | Rs6.79 Billion ≈ $73.42 Million |
+61.28% |
| 2016-03-31 | Rs4.21 Billion ≈ $45.52 Million |
-3.48% |
| 2015-03-31 | Rs4.36 Billion ≈ $47.16 Million |
+42.46% |
| 2014-03-31 | Rs3.06 Billion ≈ $33.11 Million |
+17.63% |
| 2013-03-31 | Rs2.60 Billion ≈ $28.15 Million |
+1.62% |
| 2012-03-31 | Rs2.56 Billion ≈ $27.70 Million |
+68.54% |
| 2011-03-31 | Rs1.52 Billion ≈ $16.43 Million |
+30.41% |
| 2010-03-31 | Rs1.17 Billion ≈ $12.60 Million |
-9.89% |
| 2009-03-31 | Rs1.29 Billion ≈ $13.98 Million |
+30.15% |
| 2008-03-31 | Rs993.60 Million ≈ $10.75 Million |
+4.93% |
| 2007-03-31 | Rs946.90 Million ≈ $10.24 Million |
+0.81% |
| 2006-03-31 | Rs939.30 Million ≈ $10.16 Million |
-24.15% |
| 2005-03-31 | Rs1.24 Billion ≈ $13.39 Million |
-- |
About Abbott India Limited
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, … Read more